Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Marriott

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 28, 2010
The production of 'aerodynamically equivalent' drug and excipient inhalable powders using a novel fractionation techniqueMohammed Taki, Christopher Marriott, Xian-Ming Zeng, et al.
BMJ Open|January 22, 2015
Body composition and bone health in long-term survivors of acute lymphoblastic leukaemia in childhood and adolescence: the protocol for a cross-sectional cohort studyRonald Barr, Trishana Nayiager, Christopher Gordon, et al.
International Journal of Pharmaceutics|December 23, 2009
Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactorsMohammed Taki, Christopher Marriott, Xian-Ming Zeng, et al.
Pulmonary Pharmacology & Therapeutics|December 6, 2005
The correlation of urinary levels of albuterol and its metabolites isomers following inhalation from a dry powder inhaler and in vitro particle size characterisationTeerapol Srichana, Roongnapa Suedee, Niwan Tanmanee, et al.
Pharmaceutical Research|August 11, 2006
Characterisation of a carrier-free dry powder aerosol formulation using inertial impaction and laser diffractionGary P Martin, Helen B MacRitchie, Christopher Marriott, et al.
Pharmaceutical Research|August 11, 2006
Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulationsXian-Ming Zeng, Helen B MacRitchie, Christopher Marriott, et al.
International Journal of Pharmaceutics|October 27, 2006
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriersXian-Ming Zeng, Helen B MacRitchie, Christopher Marriott, et al.
International Journal of Pharmaceutics|September 1, 2006
Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulationsChristopher Marriott, Helen B MacRitchie, Xian-Ming Zeng, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 10, 2011
The 'stage-by-stage' deposition of drugs from commercial single-active and combination dry powder inhaler formulationsMohammed Taki, Sarah Ahmed, Christopher Marriott, et al.
Journal of Nuclear Medicine Technology|October 21, 2025
Optimizing Dose Reduction of <sup>18</sup>F-FDG in Oncology PET/CT: Exploring Strategies to Minimize Radiation Exposure While Maintaining Diagnostic EfficacyFatema Al Sawafi, Adeel Ahmed, Christopher Marriott, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 28, 2010
The production of 'aerodynamically equivalent' drug and excipient inhalable powders using a novel fractionation techniqueMohammed Taki, Christopher Marriott, Xian-Ming Zeng, et al.
BMJ Open|January 22, 2015
Body composition and bone health in long-term survivors of acute lymphoblastic leukaemia in childhood and adolescence: the protocol for a cross-sectional cohort studyRonald Barr, Trishana Nayiager, Christopher Gordon, et al.
International Journal of Pharmaceutics|December 23, 2009
Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactorsMohammed Taki, Christopher Marriott, Xian-Ming Zeng, et al.
Pulmonary Pharmacology & Therapeutics|December 6, 2005
The correlation of urinary levels of albuterol and its metabolites isomers following inhalation from a dry powder inhaler and in vitro particle size characterisationTeerapol Srichana, Roongnapa Suedee, Niwan Tanmanee, et al.
Pharmaceutical Research|August 11, 2006
Characterisation of a carrier-free dry powder aerosol formulation using inertial impaction and laser diffractionGary P Martin, Helen B MacRitchie, Christopher Marriott, et al.
Pharmaceutical Research|August 11, 2006
Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulationsXian-Ming Zeng, Helen B MacRitchie, Christopher Marriott, et al.
International Journal of Pharmaceutics|October 27, 2006
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriersXian-Ming Zeng, Helen B MacRitchie, Christopher Marriott, et al.
International Journal of Pharmaceutics|September 1, 2006
Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulationsChristopher Marriott, Helen B MacRitchie, Xian-Ming Zeng, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 10, 2011
The 'stage-by-stage' deposition of drugs from commercial single-active and combination dry powder inhaler formulationsMohammed Taki, Sarah Ahmed, Christopher Marriott, et al.
Journal of Nuclear Medicine Technology|October 21, 2025
Optimizing Dose Reduction of <sup>18</sup>F-FDG in Oncology PET/CT: Exploring Strategies to Minimize Radiation Exposure While Maintaining Diagnostic EfficacyFatema Al Sawafi, Adeel Ahmed, Christopher Marriott, et al.
Pageof 3